On July 24, 2023, Robert B. Brown informed Fresh Tracks Therapeutics, Inc. of his resignation from the Company?s Board of Directors (the ?Board?), effective immediately. In submitting his resignation, Mr. Brown expressed that he is not resigning as a result of any disagreement on any matter relating to the operations, policies or practices of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9201 USD | -2.01% | +1.11% | +4.66% |
03-15 | Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
+4.66% | 5.61M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- FRTX Stock
- News Fresh Tracks Therapeutics, Inc.
- Fresh Tracks Therapeutics, Inc. Announces Resignation of Robert B. Brown from the Board of Directors, Effective Immediately